(Post-pandemic Era)-Global Assisted Reproductive Technology (ART) Market Segment Research Report 2021
Table of Contents
Global Assisted Reproductive Technology (ART) Market Segment Research Report 2021
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Assisted Reproductive Technology (ART) Market by Value
- 2.2.1 Global Assisted Reproductive Technology (ART) Revenue by Type
- 2.2.2 Global Assisted Reproductive Technology (ART) Market by Value (%)
- 2.3 Global Assisted Reproductive Technology (ART) Market by Production
- 2.3.1 Global Assisted Reproductive Technology (ART) Production by Type
- 2.3.2 Global Assisted Reproductive Technology (ART) Market by Production (%)
3. The Major Driver of Assisted Reproductive Technology (ART) Industry
- 3.1 Historical & Forecast Global Assisted Reproductive Technology (ART) Demand
- 3.2 Largest Application for Assisted Reproductive Technology (ART) (2017-2027)
- 3.3 The Major Downstream Company in China Market 2021
4. Global and Regional Assisted Reproductive Technology (ART) Market
- 4.1 Regional Market Size in Terms of Production & Demand (2021)
- 4.2 Regional Market Share in Terms of Revenue (2019-2027)
- 4.3 Concentration Ratio (CR5& CR10) of Assisted Reproductive Technology (ART) Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Assisted Reproductive Technology (ART) Production, Demand (2017-2027)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
6. Europe Assisted Reproductive Technology (ART) Production, Demand (2017-2027)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
7. China Assisted Reproductive Technology (ART) Production, Demand (2017-2027)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
8. Japan Assisted Reproductive Technology (ART) Production, Demand (2017-2027)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
9. India Assisted Reproductive Technology (ART) Production, Demand (2017-2027)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
10. Korea Assisted Reproductive Technology (ART) Production, Demand (2017-2027)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
11. Southeast Asia Assisted Reproductive Technology (ART) Production, Demand (2017-2027)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
12. Global Assisted Reproductive Technology (ART) Average Price Trend
- 12.1 Market Price for Each Type of Assisted Reproductive Technology (ART) in US (2017-2021)
- 12.2 Market Price for Each Type of Assisted Reproductive Technology (ART) in Europe (2017-2021)
- 12.3 Market Price for Each Type of Assisted Reproductive Technology (ART) in China (2017-2021)
- 12.4 Market Price for Each Type of Assisted Reproductive Technology (ART) in Japan (2017-2021)
- 12.5 Market Price for Each Type of Assisted Reproductive Technology (ART) in India (2017-2021)
- 12.6 Market Price for Each Type of Assisted Reproductive Technology (ART) in Korea (2017-2021)
- 12.7 Market Price for Each Type of Assisted Reproductive Technology (ART) in Southeast Asia (2017-2021)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Assisted Reproductive Technology (ART) Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Technology Trends of Assisted Reproductive Technology (ART)
14. Assisted Reproductive Technology (ART) Competitive Landscape
- 14.1 Irvin Scientific (U.S.)
- 14.1.1 Irvin Scientific (U.S.) Company Profiles
- 14.1.2 Irvin Scientific (U.S.) Product Introduction
- 14.1.3 Irvin Scientific (U.S.) Assisted Reproductive Technology (ART) Sales, Revenue (2017-2021)
- 14.1.4 Strategic initiatives
- 14.2 Origio A/S (Denmark)
- 14.2.1 Origio A/S (Denmark) Company Profiles
- 14.2.2 Origio A/S (Denmark) Product Introduction
- 14.2.3 Origio A/S (Denmark) Assisted Reproductive Technology (ART) Sales, Revenue (2017-2021)
- 14.2.4 Strategic initiatives
- 14.3 Microm UK Ltd (U.K.)
- 14.3.1 Microm UK Ltd (U.K.) Company Profiles
- 14.3.2 Microm UK Ltd (U.K.) Product Introduction
- 14.3.3 Microm UK Ltd (U.K.) Assisted Reproductive Technology (ART) Sales, Revenue (2017-2021)
- 14.3.4 Strategic initiatives
- 14.4 Parallabs Ltd (U.K.)
- 14.4.1 Parallabs Ltd (U.K.) Company Profiles
- 14.4.2 Parallabs Ltd (U.K.) Product Introduction
- 14.4.3 Parallabs Ltd (U.K.) Assisted Reproductive Technology (ART) Sales, Revenue (2017-2021)
- 14.4.4 Strategic initiatives
- 14.5 Cryolab Ltd. (U.K.)
- 14.5.1 Cryolab Ltd. (U.K.) Company Profiles
- 14.5.2 Cryolab Ltd. (U.K.) Product Introduction
- 14.5.3 Cryolab Ltd. (U.K.) Assisted Reproductive Technology (ART) Sales, Revenue (2017-2021)
- 14.5.4 Strategic initiatives
- 14.6 Merck KGaA (Germany)
- 14.6.1 Merck KGaA (Germany) Company Profiles
- 14.6.2 Merck KGaA (Germany) Product Introduction
- 14.6.3 Merck KGaA (Germany) Assisted Reproductive Technology (ART) Sales, Revenue (2017-2021)
- 14.6.4 Strategic initiatives
- 14.7 Vitrolife AB (Sweden)
- 14.7.1 Vitrolife AB (Sweden) Company Profiles
- 14.7.2 Vitrolife AB (Sweden) Product Introduction
- 14.7.3 Vitrolife AB (Sweden) Assisted Reproductive Technology (ART) Sales, Revenue (2017-2021)
- 14.7.4 Strategic initiatives
- 14.8 ...
- 14.8.1 ... Company Profiles
- 14.8.2 ... Product Introduction
- 14.8.3 ... Assisted Reproductive Technology (ART) Sales, Revenue (2017-2021)
- 14.8.4 Strategic initiatives
15. Conclusion
Summary
The global economy is expected to expand 5.6% in 2021,global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic Prospects: Growth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global Assisted Reproductive Technology (ART) market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to XYZResearch analysis, The segment in Assisted Reproductive Technology (ART) market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Assisted Reproductive Technology (ART) production is XX (K Units). US market value in 2021 is about USD XX billion, and US Assisted Reproductive Technology (ART) production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Assisted Reproductive Technology (ART) production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Assisted Reproductive Technology (ART) Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Assisted Reproductive Technology (ART) Market?
Irvin Scientific (U.S.)
Origio A/S (Denmark)
Microm UK Ltd (U.K.)
Parallabs Ltd (U.K.)
Cryolab Ltd. (U.K.)
Merck KGaA (Germany)
Vitrolife AB (Sweden)
...
Major Type of Assisted Reproductive Technology (ART) Covered in XYZResearch report:
In-Vitro Fertilization
Artificial Insemination
Others
Application Segments Covered in XYZResearch Market
Hospitals
Fertility Clinics
Others
For any other requirements, please feel free to contact us and we will provide you customized report.